The FASEB Journal · 2013 · 25 citations · 47 references
Life SciencesPharmacologyPhysiologyCell SignalingMolecular PharmacologySignal TransductionCardiovascular PharmacodynamicsCardiovascular PharmacologyCardiovascular PhysiologyEndothelial ActivationVasodilator TherapyAgonist ActivityNitric OxideNitric Oxide Synthase RegulationPhospholipase C PathwayPhospholipase C SignalingTranscriptsVascular Tone ModulationVasodilator Pharmacology
Lysophosphatidic acid (LPA) has been implicated as a mediator of several cardiovascular functions, but its potential involvement in the control of vascular tone is obscure. Here, we show that both LPA (18:1) and VPC31143 (a synthetic agonist of LPA 1–3 receptors) relax intact mouse thoracic aorta with similar E max values (53.9 and 51.9% of phenylephrine‐induced precontraction), although the EC 50 of LPA‐ and VPC31143‐induced vasorelaxations were different (400 vs. 15 nM, respectively). Mechanical removal of the endothelium or genetic deletion of endothelial nitric oxide synthase (eNOS) not only diminished vasorelaxation by LPA or VPC31143 but converted it to vasoconstriction. Freshly isolated mouse aortic endothelial cells expressed LPA 1 , LPA 2 , LPA 4 and LPA 5 transcripts. The LPA 1–3 antagonist Ki16425, the LPA 1 antagonist AM095, and the genetic deletion of LPA 1 , but not that of LPA 2 , abolished LPA‐induced vasorelaxation. Inhibition of the phosphoinositide 3 kinase‐protein kinase B/Akt pathway by wortmannin or MK‐2206 failed to influence the effect of LPA. However, pharmacological inhibition of phospholipase C (PLC) by U73122 or edelfosine, but not genetic deletion of PLCε, abolished LPA‐induced vasorelaxation and indicated that a PLC enzyme, other than PLCε, mediates the response. In summary, the present study identifies LPA as an endothelium‐dependent vasodilator substance acting via LPA 1 , PLC, and eNOS.—Ruisanchez, É., Dancs, P., Kerék, M., Németh, T., Faragó, B., Balogh, A., Patil, R., Jennings, B. L., Liliom, K., Malik, K. U., Smrcka, A. V., Tigyi, G., Benyó, Z. Lysophosphatidic acid induces vasodilation mediated by LPA 1 receptors, phospholipase C, and endothelial nitric oxide synthase. FASEB J. 28, 880–890 (2014). www.fasebj.org
47
Jonathan H. Hecht, Joshua A. Weiner, Steven R. Post et al. · The Journal of Cell Biology · 1996 · 732 citations · Full text
Wolfgang Siess, Konrad J. Zangl, Markus Essler et al. · Proceedings of the National Academy of Sciences · 1999 · 405 citations · Full text
Medicine, Biochemistry, Cardiology +17